Special Issue "New Developments in Pediatric Drug Formulations"
Deadline for manuscript submissions: closed (30 December 2021).
Interests: drug formulations; pediatrics; pediatric oncology; extemporaneous preparation; drug administration
Interests: physiologically based pharmacokinetic (PBPK) modeling; in vitro-in vivo correlations (IVIVC); drug absorption; biopharmaceutics; precision medicines; in vitro dissolution-biorelevant/ compendial methods; dissolution imaging; biowaivers; pharmacometrics; animal models; formulation development; poor solubility
A well-designed pediatric drug formulation is a vital part of drug treatment. The compliance of (young) children depends heavily on the acceptability of the (oral) formulation, which will in turn be determined by factors such as taste and the texture of the dosage form. Drug safety is also an important issue in pharmacotherapy, and dosage errors can be easily made when a drug formulation is not well adjusted to the patient. In daily practice, extemporaneously prepared drug formulations or manipulation by caregivers are still common practice, and quality issues have to be described.
All these aspects have shifted the focus to the development of new drug formulations that are suitable for use in pediatrics, such as 3D printing, minitablets, and oromucosal films. In this issue, new developments are described.
Dr. Lidwien Marieke Hanff
Dr. Nikoletta Fotaki
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug formulation
- 3D printing
- oromucosal film